IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis

Molecular Immunology - Tập 64 - Trang 152-162 - 2015
Wenjing Cheng1, Qing Zhao1, Yebin Xi1, Chengzhen Li1, Yunzhi Xu1, Li Wang1, Xiaoyin Niu1, Zhaojun Wang1, Guangjie Chen1
1Department of Immunology and Microbiology, Shanghai JiaoTong University School of Medicine, Shanghai Institute of Immunology, PR China

Tài liệu tham khảo

Acosta-Rodriguez, 2007, Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells, Nat. Immunol., 8, 639, 10.1038/ni1467 Aktas, 2003, Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin, J. Exp. Med., 197, 725, 10.1084/jem.20021425 Alvarez, 2011, Disruption of central nervous system barriers in multiple sclerosis, Biochim. Biophys. Acta, 1812, 252, 10.1016/j.bbadis.2010.06.017 Axtell, 2010, T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis, Nat. Med., 16, 406, 10.1038/nm.2110 Cabrelle, 2008, Hyperforin down-regulates effector function of activated T lymphocytes and shows efficacy against Th1-triggered CNS inflammatory-demyelinating disease, J. Leukoc. Biol., 83, 212, 10.1189/jlb.0707469 Chen, 2012, IFN-beta induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis, J. Neuroimmunol., 242, 39, 10.1016/j.jneuroim.2011.10.014 Chen, 2009, Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS, Eur. J. Immunol., 39, 2525, 10.1002/eji.200838879 Cheng, 2014, Chemokines and chemokine receptors in multiple sclerosis, Mediators Inflamm., 2014, 659206, 10.1155/2014/659206 Dutra, 2013, The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: evidence for the involvement of astrocytes, Neurobiol. Dis., 54, 82, 10.1016/j.nbd.2013.02.007 Eltayeb, 2007, Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE, J. Neuroinflamm., 4, 14, 10.1186/1742-2094-4-14 Fitzgerald, 2013, Independent and interdependent immunoregulatory effects of IL-27, IFN-beta, and IL-10 in the suppression of human Th17 cells and murine experimental autoimmune encephalomyelitis, J. Immunol. (Baltimore, MD: 1950), 190, 3225, 10.4049/jimmunol.1200141 Ford, 2003, Regulation of polyclonal T cell responses by an MHC anchor-substituted variant of myelin oligodendrocyte glycoprotein 35–55, J. Immunol. (Baltimore, MD: 1950), 171, 1247, 10.4049/jimmunol.171.3.1247 Haanstra, 2013, Induction of experimental autoimmune encephalomyelitis with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant in three non-human primate species, J. Neuroimmune Pharmacol., 8, 1251, 10.1007/s11481-013-9487-z Hackett, 2014, Transplantation of Fas-deficient or wild-type neural stem/progenitor cells (NPCs) is equally efficient in treating experimental autoimmune encephalomyelitis (EAE), Am. J. Transl. Res., 6, 119 Hidaka, 2014, Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-gamma and TNF-alpha are important participants in the first attack but not in the relapse, J. Neurol. Sci., 340, 117, 10.1016/j.jns.2014.02.039 Holman, 2011, The blood–brain barrier, chemokines and multiple sclerosis, Biochim. Biophys. Acta, 1812, 220, 10.1016/j.bbadis.2010.07.019 Huss, 2011, TGF-beta signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE, Eur. J. Immunol., 41, 2987, 10.1002/eji.201141666 Ito, 2003, Transfer of severe experimental autoimmune encephalomyelitis by IL-12- and IL-18-potentiated T cells is estrogen sensitive, J. Immunol. (Baltimore, MD: 1950), 170, 4802, 10.4049/jimmunol.170.9.4802 Ivanov, 2006, The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells, Cell, 126, 1121, 10.1016/j.cell.2006.07.035 Kaushansky, 2006, Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J mice, J. Immunol. (Baltimore, MD: 1950), 177, 7364, 10.4049/jimmunol.177.10.7364 Kim, 2014, 27-Hydroxycholesterol and 7alpha-hydroxycholesterol trigger a sequence of events leading to migration of CCR5-expressing Th1 lymphocytes, Toxicol. Appl. Pharmacol., 274, 462, 10.1016/j.taap.2013.12.007 Klein, 2004, IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis, J. Immunol. (Baltimore, MD: 1950), 172, 550, 10.4049/jimmunol.172.1.550 Lalor, 2013, Th1-mediated experimental autoimmune encephalomyelitis is CXCR3 independent, Eur. J. Immunol., 43, 2866, 10.1002/eji.201343499 Lazarski, 2013, IL-4 attenuates Th1-associated chemokine expression and Th1 trafficking to inflamed tissues and limits pathogen clearance, PLOS ONE, 8, e71949, 10.1371/journal.pone.0071949 Leist, 2014, Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial, Lancet Neurol., 13, 257, 10.1016/S1474-4422(14)70005-5 Liu, 2014, Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality, J. Neurol. Sci., 341, 8, 10.1016/j.jns.2014.03.029 Lopez-Ramirez, 2014, MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation, FASEB J., 28, 2551, 10.1096/fj.13-248880 Mahurkar, 2014, Pharmacogenomics of interferon beta and glatiramer acetate response: a review of the literature, Autoimmun. Rev., 13, 178, 10.1016/j.autrev.2013.10.012 Martin-Saavedra, 2008, Beta interferon restricts the inflammatory potential of CD4+ cells through the boost of the Th2 phenotype, the inhibition of Th17 response and the prevalence of naturally occurring T regulatory cells, Mol. Immunol., 45, 4008, 10.1016/j.molimm.2008.06.006 Moriguchi, 2013, The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis, J. Neuroimmunol., 257, 53, 10.1016/j.jneuroim.2013.02.002 Muili, 2013, Photobiomodulation induced by 670nm light ameliorates MOG35-55 induced EAE in female C57BL/6 mice: a role for remediation of nitrosative stress, PLOS ONE, 8, e67358, 10.1371/journal.pone.0067358 O’Connor, 2013, T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease, Eur. J. Immunol., 43, 2818, 10.1002/eji.201343689 Ogretmen, 2001, Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells, J. Biol. Chem., 276, 24901, 10.1074/jbc.M100314200 Qin, 2010, Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberine, J. Immunol. (Baltimore, MD: 1950), 185, 1855, 10.4049/jimmunol.0903853 Ryu, 2013, Gene therapy of multiple sclerosis using interferon beta-secreting human bone marrow mesenchymal stem cells, Biomed. Res. Int., 2013, 696738, 10.1155/2013/696738 Sagar, 2012, Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation, J. Neuroinflamm., 9, 245, 10.1186/1742-2094-9-245 Sato, 2012, CCR2(+)CCR5(+) T cells produce matrix metalloproteinase-9 and osteopontin in the pathogenesis of multiple sclerosis, J. Immunol. (Baltimore, MD: 1950), 189, 5057, 10.4049/jimmunol.1202026 Scagnolari, 2014, In vitro assessment of the biologic activity of interferon beta formulations used for the treatment of relapsing multiple sclerosis, J. Immunoassay Immunochem., 35, 288, 10.1080/15321819.2013.848815 Serada, 2008, IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis, Proc. Natl. Acad. Sci. U. S. A., 105, 9041, 10.1073/pnas.0802218105 Serafini, 2000, Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis, Am. J. Pathol., 157, 1991, 10.1016/S0002-9440(10)64838-9 Serres, 2013, Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis, J. Cereb. Blood Flow Metab., 33, 744, 10.1038/jcbfm.2013.12 Skundric, 2005, Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE, J. Neurosci. Res., 79, 680, 10.1002/jnr.20377 Szczucinski, 2007, Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies, Acta Neurol. Scand., 115, 137, 10.1111/j.1600-0404.2006.00749.x Tuohy, 2000, Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis, J. Neuroimmunol., 111, 55, 10.1016/S0165-5728(00)00384-2 Tzartos, 2008, Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis, Am. J. Pathol., 172, 146, 10.2353/ajpath.2008.070690 Williams, 1994, Immunology of multiple sclerosis, Clin. Neurosci. (New York, N.Y.), 2, 229 Wojkowska, 2014, Interactions between neutrophils, Th17 cells, and chemokines during the initiation of experimental model of multiple sclerosis, Mediators Inflamm., 2014, 590409, 10.1155/2014/590409 Zhang, 2013, Aurintricarboxylic acid ameliorates experimental autoimmune encephalomyelitis by blocking chemokine-mediated pathogenic cell migration and infiltration, J. Immunol. (Baltimore, MD: 1950), 190, 1017, 10.4049/jimmunol.1201994 Zhou, 2014, Differential IL-10 production by DCs determines the distinct adjuvant effects of LPS and PTX in EAE induction, Eur. J. Immunol., 44, 1352, 10.1002/eji.201343744